Farallon Capital Management LLC Bolt Biotherapeutics, Inc. Transaction History

Farallon Capital Management LLC

  • $23.1 Billion
  • Q3 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
BUY
$25.86 - $39.93 $6.47 Million - $9.98 Million
250,000 New
250,000 $8.23 Million

Others Institutions Holding BOLT

# of Institutions
2
Shares Held
682K
Call Options Held
0
Put Options Held
0
View Full List

About Bolt Biotherapeutics, Inc.

BOLT Quotes by TradingView
  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $169M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email